LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

Search

Masimo Corp

Geschlossen

BrancheGesundheitswesen

155.26 0.57

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

152.92

Max

155.44

Schlüsselkennzahlen

By Trading Economics

Einkommen

179M

-171M

Verkäufe

-229M

372M

KGV

Branchendurchschnitt

118.556

56.602

EPS

1.36

Gewinnspanne

-45.887

Angestellte

3,600

EBITDA

-367M

-321M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+22.81% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

5. Aug. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-635M

8.9B

Vorheriger Eröffnungskurs

154.69

Vorheriger Schlusskurs

155.26

Nachrichtenstimmung

By Acuity

72%

28%

351 / 382 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Very Strong Bearish Evidence

Masimo Corp Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

6. Mai 2025, 20:32 UTC

Top News
Akquisitionen, Fusionen, Übernahmen

Masimo to Sell Audio Business to Harman in $350 Million Deal -- Update

6. Mai 2025, 20:12 UTC

Akquisitionen, Fusionen, Übernahmen

Masimo: Divestiture Supports Focus on Core Professional Healthcare Business >MASI

6. Mai 2025, 20:12 UTC

Akquisitionen, Fusionen, Übernahmen

Masimo to Sell Sound United Consumer Audio Business to Samsung's HARMAN for $350 M in Cash >MASI

6. Mai 2025, 20:00 UTC

Top News
Akquisitionen, Fusionen, Übernahmen

Masimo to Sell Audio Business to Harman After Investor Outrage -- WSJ

6. Mai 2025, 20:00 UTC

Akquisitionen, Fusionen, Übernahmen

Harman International Nears $350M Deal for Masimo's Consumer Audio Business, Sources Say -- WSJ

6. Mai 2025, 20:00 UTC

Akquisitionen, Fusionen, Übernahmen

Deal Could be Finalized as Soon as Later Tuesday, Sources Say -- WSJ

Peer-Vergleich

Kursveränderung

Masimo Corp Prognose

Kursziel

By TipRanks

22.81% Vorteil

12-Monats-Prognose

Durchschnitt 189.6 USD  22.81%

Hoch 200 USD

Tief 180 USD

Basierend auf 6 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Masimo Corp – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

6 ratings

5

Buy

1

Halten

0

Sell

Technischer Score

By Trading Central

142.8 / 163.949Unterstützung & Widerstand

Kurzfristig

Very Strong Bearish Evidence

Mittelfristig

Very Strong Bearish Evidence

Langfristig

Bearish Evidence

Stimmung

By Acuity

351 / 382 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bärische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Masimo Corp

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Patient SafetyNet Surveillance, SafetyNet, Replica, Iris, MyView, UniView, Uniview: 60, Masimo Sleep, Centroid, and Bridg; and nasal high-flow ventilation, neuromodulation therapeutics, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and home wellness products through e-commerce internet sites, such as masimopersonalhealth.com, amazon.com, and shopify.com. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.